Visualizing head and neck tumors in vivo using near-infrared fluorescent transferrin conjugate

Molecular Imaging

Volumn 7, Issue 1, 2008, Pages 42-49

  Shan, Liang ^b   Hao, Yubin ^b   Wang, Songping ^b   Korotcov, Alexandru ^b   Zhang, Renshu ^b   Wang, Tongxin ^b   Califano, Joseph ^b   Gu, Xinbin ^b   Sridhar, Rajagopalan ^b   Bhujwalla, Zaver M ^b   Wang, Paul C ^a  

^a HOWARD UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

(R ,S)-CONJUGATE; HEAD AND NECK TUMORS; HUMAN HEAD; IN-VIVO; NEAR INFRA-RED (NIR); SQUAMOUS CELL CARCINOMAS (SCC); TRANSFERRIN (TF); TRANSFERRIN RECEPTORS;

FLUORESCENCE; LIGHT EMISSION; LUMINESCENCE; PLASMA (HUMAN);

INFRARED DEVICES;

TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; DISEASE MODEL; ENDOCYTOSIS; EXOCYTOSIS; FLUORESCENCE; HEAD AND NECK TUMOR; HUMAN; INFRARED RADIATION; METABOLISM; MOUSE; PATHOLOGY; TUMOR CELL LINE; WHOLE BODY IMAGING;

ANIMALS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; ENDOCYTOSIS; EXOCYTOSIS; FLUORESCENCE; HEAD AND NECK NEOPLASMS; HUMANS; INFRARED RAYS; MICE; NEOPLASM TRANSPLANTATION; RECEPTORS, TRANSFERRIN; TRANSFERRIN; WHOLE BODY IMAGING;

EID: 44949149083     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2008.0006     Document Type: Article

References (27)

1. Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Gene Dev 2003;17:545-80.
2. Graves EE, Weissleder R, Ntziachristos V. Fluorescence molecular imaging of small animal tumor models. Curr Mol Med 2004;4: 419-30.
3. Ntziachristos V, Bremer C, Weissleder R. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003;13:195-208.
4. Hogemann-Savellano D, Bos E, Blondet C, et al. The transferrin receptor: a potential molecular imaging marker for human cancer. Neoplasia 2003;5:495-506.
5. Stefflova K, Chen J, Zheng G. Using molecular beacons for cancer imaging and treatment. Front Biosci 2007;12:4709-21.
6. Hoffman RM. The multiple uses of fluorescent proteins to visualize cancer in vivo. Nature 2005;5:796-806.
7. Veiseh M, Gabikian P, Bahrami SB, et al. Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci. Cancer Res 2007;67:6882-8.
8. Kaijzel EL, van der Pluijm G, Lowik CW. Whole-body optical imaging in animal models to assess cancer development and progression. Clin Cancer Res 2007;13:3490-7.
9. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
10. Forastiere A, Koch W, Trotti A, Sidransky D. Head and neck cancer. N Engl J Med 2001;345:1890-900.
11. Westra WH, Califano J. Toward early oral cancer detection using gene expression profiling of saliva: a thoroughfare or dead end? Clin Cancer Res 2004;10:8130-1.
12. Pirollo K, Dagata J, Wang P, et al. A tumor-targeted nanodelivery system to improve early MRI detection of cancer. Mol Imaging 2006;5:41-52.
13. Shan L, Wang S, Sridhar R, et al. A dual probe with fluorescent and magnetic properties for imaging solid tumor xenografts. Mol Imaging 2007;6:85-95.
14. Bellocq NC, Pun SH, Jensen GS, Davis ME. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug Chem 2003;14:1122-32.
15. Smith TA, Perkins AC, Walton PH. 99mTc-labelled human serum transferrin for tumour imaging: an in vitro and in vivo study of the complex. Nucl Med Commun 2004;25:387-91.
16. Vavere AL, Welch MJ. Preparation, biodistribution, and small animal PET of 45Ti-transferrin. J Nucl Med 2005;46:683-90.
17. Miyamoto T, Tanaka N, Eishi Y, Amagasa T. Transferrin receptor in oral tumors. Int J Oral Maxillofac Surg 1994;23:430-3.
18. Kearsley JH, Furlong KL, Cooke RA, Waters MJ. An immunohis-tochemical assessment of cellular proliferation markers in head and neck squamous cell cancers. Br J Cancer 1990;61:821-7.
19. Tanaka N, Miyamoto T, Saito M, et al. Transferrin receptor expression in oral tumors. Bull Tokyo Med Dent Univ 1991;38:l9-26.
20. Dickson M, Hahn W, Ino Y, et al. Human keratinocytes that express hTERT and also bypass a pl6INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000;20:1436-47.
21. Klausner RD, Renswoude JV, Ashwell G, et al. Receptor-mediated endocytosis of transferrin in K562 cells. J Biol Chem l982;258: 4715-24.
22. Zhang W, Moorthy B, Chen M, et al. A Cypla2-luciferase transgenic CD-1 mouse model: responses to aryl hydrocarbons similar to the humanized AhR mice. Toxicol Sci 2004;82: 297-307.
23. Pillon A, Servant N, Vignon F, et al. In vivo bioluminescent imaging to evaluate estrogenic activities of endocrine disrupters. Analyt Biochem 2005;340:295-302.
24. Raman V, Artemov D, Pathak AP, et al. Characterizing vascular parameters in hypoxic regions: a combined magnetic resonance and optical imaging study of a human prostate cancer model. Urol Oncol 2007;25:358-9.
25. Kanematsu M, Semelka R, Osada S, Amaoka N. Magnetic resonance imaging and expression of vascular endothelial growth factor in hepatocellular nodules in cirrhosis and hepatocellular carcinomas. Top Magn Reson Imaging 2005;16:67-75.
26. Hoffman A, Goetz M, Vieth M, et al. Confocal laser endomicroscopy: technical status and current indications. Endoscopy 2006;38: 1275-83.
27. Gomme PT, McCann KB, Bertolini J. Transferrin: structure, function and potential therapeutic actions. Drug Discov Today 2005;10:267-73.